Inducible brain COX-2 facilitates the recurrence of hippocampal seizures in mouse rapid kindling

Prostaglandins and Other Lipid Mediators

Volumn 71, Issue 3-4, 2003, Pages 205-216

  Takemiya, Takako ^a,b   Suzuki, Kyoko ^b   Sugiura, Hiroko ^b   Yasuda, Shin ^b   Yamagata, Kanato ^b   Kawakami, Yoriko ^a   Maru, Eiichi ^c  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Brain COX 2; Hippocampal seizures; PGE2; Rapid kindling

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; NIMESULIDE;

AFTERDISCHARGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; ELECTROSTIMULATION; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; HIPPOCAMPUS; IN SITU HYBRIDIZATION; KINDLING; KNOCKOUT MOUSE; MOUSE; NERVE CELL; NONHUMAN; PROTEIN EXPRESSION; SEIZURE;

EID: 0042208265     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1098-8823(03)00040-6     Document Type: Article

References (30)

1. Hayaishi O., Matsumura H. Prostaglandins and sleep. Adv. Neuroimmunol. 5:1995;211-216.
2. Nogawa S., Zhang Fv., Ross M.E., Iadecola C. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J. Neurosci. 17:1997;2746-2755.
3. Matsumura K., Cao C., Watanabe Y., Watanabe Y. Prostaglandin system in the brain: sites of biosynthesis and sites of action under normal and hyperthermic states. Prog. Brain Res. 115:1998;275-295.
4. Lysz T.W., Centra M., Markey K., Keeting P.E. Evidence for increased activity of mouse brain fatty acid cyclooxygenase following drug-induced convulsions. Brain Res. 408:1987;6-12.
5. Naffah-Mazzacoratti M.G., Bellissimo M.I., Cavalheiro E.A. Profile of levels in the rat hippocampus in pilocarpine model of epilepsy. Neurochem. Int. 27:1995;461-466.
6. Wallenstein M.C. Attenuation of epileptogenesis by nonsteroidal anti-inflammatory drugs in the rat. Neuropharmacology. 30:1991;657-663.
7. Bhaduri J., Hota D., Acharya S.B. Role of prostaglandin synthesis inhibitors on chemically induced seizures. Indian J. Exp. Biol. 33:1995;677-681.
8. 2. Epilepsy Res. 30:1998;63-68.
9. Miyamoto T., Ogino N., Yamamoto S., Hayaishi O. Purification of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes. J. Biol. Chem. 251:1976;2629-2636.
10. Simmons D.L., Levy D.B., Yannoni Y., Erikson R.L. Identification of a phorbol ester-repressible v-src-inducible gene. Proc. Natl. Acad. Sci. U.S.A. 86:1989;1178-1182.
11. Yamagata K., Andreasson K.I., Kaufmann W.E., Barnes C.A., Worley P.F. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron. 11:1993;371-386.
12. Marcheselli V.L., Bazan N.G. Sustained induction of prostaglandin endoperoxide synthase-2 by seizures in hippocampus. J. Biol. Chem. 271:1996;24794-24799.
13. Taniguchi Y., Yokoyama K., Inui K., Deguchi Y., Furukawa K., Noda K. Inhibition of brain cyclooxygenase-2 activity and the antipyretic action of nimesulide. Eur. J. Neurosci. 330:1997;221-229.
14. Dinchuk J.E., Car B.D., Focht R.J., Johnston J.J., Jaffee B.D., Covington M.B.et al. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature. 378:1995;406-409.
15. Morham S.G., Langenbach R., Loftin C.D., Tiano H.F., Vouloumanos N., Jennette J.C.et al. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell. 83:1995;473-482.
16. Bengzon J., Okabe S., Lindvall O., McKay R.D.G. Suppression of epileptogenesis by modification of N-methyl-D-aspartate receptor subunit composition. Eur. J. Neurosci. 11:1999;916-922.
17. Lothman E.W., Hatlelid J.M., Zorumski C.F., Conry J.A., Moon P.F., Perlin J.B. Kindling with rapidly recurring hippocampal seizures. Brain Res. 360:1985;83-91.
18. Powell WS. Rapid extraction of arachidonic acid metabolites from biological samples using octadecylsilyl silica. In: Lands WEM, Smith WL, editors. Methods in enzymology. Orlando, FL: Academic Press; 1982. p. 467-77.
19. Taniguchi Y., Ikesue A., Yokoyama K., Noda K., Debuchi H., Nakamura T.et al. Selective inhibition by Nimesulide a novel non-steroidal anti-inflammatory drug, with prostaglandin endoperoxide synthase-2 activity in vitro. Pharm. Sci. 1:1995;173-175.
20. Tavares I.A., Bishai P.M., Bennett A. Activity of Nimesulide on constitutive and inducible cyclooxygenases. Arzneimittelforschung/Drug Res. 45:1995;1093-1095.
21. 2 facilitates excitatory synaptic transmission in the nucleus tractus solitarii of rats. Neurosci. Lett. 188:1995;101-104.
22. 2 stimulates glutamate release from synaptosomes of rat spinal cord. Neurosci. Lett. 196:1995;57-60.
23. Bezzi P., Carmignoto G., Pasti L., Vesce S., Rossi D., Rizzini B.L.et al. Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature. 391:1998;281-285.
24. Nicol G.D., Vasko M.R., Evans A.R. Prostaglandins suppress an outward potassium current in embryonic rat sensory neurons. J. Neurophysiol. 77:1997;167-176.
25. 3 subtype of putative serotonergic neurons in the dorsal raphe nucleus of the rat. Naunyn Schmiedebergs Arch. Pharmacol. 353:1996;377-381.
26. Mucha R.F., Pinel J.P.J. Postseizure inhibition of kindled seizures. Exp. Neurol. 54:1977;266-282.
27. Timofeeva O.A. Apparent disaapearance of postseizure inhibitions and intensity of seizures during the development of rapid kindling in rabbits. Neurosci. Lett. 135:1992;163-166.
28. Handforth A. Postseizure inhibition of kindled seizures by electroconvulsive shock. Exp. Neurol. 78:1982;483-491.
29. Aminoff MJ, Parent JM. In: Engel Jr J, Pedley TA, editors. Epilepsy: a comprehensive textbook. Comorbidity in adults. Philadelphia: Lippincott-Raven; 1997. p. 1957.
30. Raskin NH, Fishman RA. Neurologic disorders in renal failure. N Engl J Med 1996;294:143-8, 204-10.